FENNEC PHARMACEUTICALS INC's ticker is FENC and the CUSIP is 31447P100. A total of 41 filers reported holding FENNEC PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,070 | -43.6% | 4,004 | -33.7% | 0.00% | – |
| Q2 2023 | $53,307 | -73.9% | 6,037 | -81.6% | 0.00% | – |
| Q1 2021 | $204,000 | -19.4% | 32,818 | -3.3% | 0.00% | – |
| Q4 2020 | $253,000 | +28.4% | 33,934 | +4.2% | 0.00% | – |
| Q3 2020 | $197,000 | -27.6% | 32,568 | 0.0% | 0.00% | – |
| Q2 2020 | $272,000 | +198.9% | 32,568 | +74.4% | 0.00% | – |
| Q1 2019 | $91,000 | -23.5% | 18,673 | 0.0% | 0.00% | – |
| Q4 2018 | $119,000 | -16.2% | 18,673 | +7.7% | 0.00% | – |
| Q3 2018 | $142,000 | -21.5% | 17,340 | 0.0% | 0.00% | – |
| Q2 2018 | $181,000 | – | 17,340 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Solas Capital Management, LLC | 849,979 | $3,400,000 | 3.47% |
| Southpoint Capital Advisors LP | 3,997,214 | $15,989,000 | 0.60% |
| Opaleye Management Inc. | 295,000 | $1,180,000 | 0.36% |
| 683 Capital Management, LLC | 971,351 | $3,885,000 | 0.35% |
| Avoro Capital Advisors LLC | 1,105,999 | $4,424,000 | 0.15% |
| Eventide Asset Management | 720,000 | $2,880,000 | 0.09% |
| Granahan Investment Management | 439,083 | $1,756,000 | 0.09% |
| Hartford Financial Management Inc. | 20,300 | $81,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 75,236 | $301,000 | 0.01% |
| Paloma Partners Management Co | 54,400 | $218,000 | 0.00% |